11 December 2023Candesic Managing Partner Dr Leonid Shapiro and Principal Dr Joe Taylor discuss in an article in PharmaTimes Media Ltd how quantum computers can contribute to the development…- 7 December 2023Candesic Senior Partner Dr Michelle Tempest joined Abdul Rahyead as a guest on a new episode of The Scrubbed In Show Podcast. The conversation centered on the transition…
- 6 December 2023Candesic Senior Partner and Cambridge Angels Investor Dr Michelle Tempest, featured in a report reviewing the UK's AI corporate ecosystem. The report was brought…
- 4 December 2023Dr Michelle Tempest, Senior Partner at Candesic, featured in the Financial Times discussing the implications of increased reliance of the NHS on private providers. Private sector…
- 28 November 2023Candesic Senior Partner Dr Michelle Tempest discusses in Healthcare Business International the constraints for the NHS to deliver on its targets. The financial pressure on the NHS makes outsourcing…
- 18 November 2023By 2030, the 50-plus population is projected to be a significant driver of consumer growth in the longevity market, representing…
- 6 November 2023Candesic Senior Partner Dr Michelle Tempest contributed her perspective to The Guardian on Daye’s innovative STI diagnostic tampon which allows convenient testing at-home. The British start-up's innovative…
- 2 November 2023HealthInvestor features Dr Michelle Tempest, Senior Partner at Candesic, commenting on the government’s AI Life Sciences Accelerator Mission £100 million fund. The fund will…
- 1 November 2023Government initiatives such as the £100m investment programme to accelerate use of AI in life sciences, and the AI Safety…
- 24 October 2023Senior partner at Candesic Dr Michelle Tempest shared in the Financial Times her views on the complex dynamics currently affecting the UK’s private healthcare sector. The recent…
